Latest 10-Q quarterly reports

Mesa Laboratories, Inc. announced its first-quarter results, showing a 1.0% increase in revenue to $60.1 million and a 2.9 percentage point improvement in gross profit margin, though net income declined.

Mistras Group, Inc. announced Q2 2026 results with increased revenue and net income, alongside a significant extension of its credit facility maturity date.

Fifth District Bancorp, Inc. reported a substantial decrease in net income for the second quarter of 2026 compared to the prior year, primarily due to the absence of a significant insurance proceeds gain, though net interest income showed improvement.

BRT Apartments Corp. announced its second quarter 2026 financial results, reporting a net loss attributable to common stockholders of $3.22 million, an increase from the prior year's loss, alongside a slight rise in total revenues.

Sable Offshore Corp. filed its Q2 2026 Form 10-Q, detailing significant net losses, a substantial debt refinancing, and ongoing legal and regulatory disputes impacting its operations and financial outlook.

JBS N.V. reported a substantial drop in net income and Adjusted EBITDA for the six-month period ended June 30, 2026, driven by increased costs and finance expenses, alongside a disclosed material weakness in internal controls.

Ur-Energy Inc. reports progress in ramping up uranium production at its Lost Creek and Shirley Basin projects, alongside increased operating costs and continued net losses.

RadNet, Inc. (RDNT) announced robust Q2 2026 results, with total service revenue up 25% year-over-year, driven by significant growth in its Imaging Centers and Digital Health segments, bolstered by strategic acquisitions.

Plug Power Inc. reported mixed financial results for Q2 2026, with revenue increases in services and fuel delivery offset by significant net losses and a substantial increase in warrant liabilities.

ACV Auctions Inc. announced its financial results for the second quarter ended June 30, 2026, showcasing revenue growth driven by marketplace and service offerings, alongside efforts to manage operating expenses.

FiscalNote Holdings, Inc. reported significant financial deterioration in its Q2 2026 Form 10-Q, marked by substantial net losses, a going concern warning, and a recent delisting from the NYSE, signaling severe operational and financial challenges.

Gold Rock Holdings, Inc. filed its Q2 2026 Form 10-Q, detailing revenue growth driven by its K-Project AI division and the ZoneX app, while continuing to address its accumulated deficit and internal control weaknesses.

Nu Skin Enterprises experienced a substantial net loss of $249.8 million in Q2 2026, driven by a 17.1% revenue decrease and a significant goodwill impairment charge.

Archer Aviation Inc. (ACHR) filed its Form 10-Q for the quarter ended June 30, 2026, reporting a net loss of $263.2 million and increased operating expenses, while also detailing strategic acquisitions and ongoing legal proceedings.

Galaxy Digital Inc. reported a net loss of $85.3 million for Q2 2026, a significant shift from the prior year's net income, driven by decreased digital asset trading volumes and prices.

Astrana Health, Inc. (ASTH) announced robust financial results for the second quarter ended June 30, 2026, showcasing significant revenue increases and improved net income, largely driven by the strategic acquisition of Prospect Medical Holdings.

Apollo Commercial Real Estate Finance, Inc. announces plans for dissolution and liquidation following a substantial $8.6 billion sale of its commercial real estate loan portfolio.

SmartFinancial Inc. announced a significant increase in net income for the second quarter and first six months of 2026, driven by higher net interest income and loan growth.

Riot Platforms, Inc. filed its Q2 2026 Form 10-Q, detailing a strategic pivot towards data center solutions alongside its bitcoin mining operations, while reporting a significant net loss.

TPG Mortgage Investment Trust, Inc. (MITT) reported its Q2 2026 financial results, highlighting a book value per share of $10.00 and net income available to common stockholders of $0.29 per diluted share, alongside a significant merger announcement with Cherry Hill Mortgage Investment Corporation.

Interpace Biosciences, Inc. filed its Q2 2026 Form 10-Q, detailing a revenue decrease but improved gross profit and operating income compared to the prior year, driven by a strategic shift following the loss of PancraGEN reimbursement.

Cherry Hill Mortgage Investment Corporation reported its Q2 2026 results, showing stable net interest income and gains from derivatives, while managing unrealized losses on its RMBS and MSR portfolios.

BioForce Nanosciences Holdings, Inc. reported its Q2 2026 financial results, highlighting a strategic pivot to the oil and gas industry and a net income of $238,682 for the quarter, contrasting with a net loss in the prior year.

OppFi Inc. announced its second-quarter 2026 financial results, highlighting a significant increase in net income and earnings per share compared to the prior year, alongside progress on its acquisition of BNCCORP, Inc. and a completed corporate simplification.

Red Violet, Inc. announced robust second-quarter 2026 financial results, highlighted by a 23% increase in revenue and an 85% surge in net income, alongside the successful closing of a $109 million public offering.

GoPro reported a significant revenue drop and increased net loss for the six months ended June 30, 2026, highlighting ongoing financial challenges and substantial doubt about its ability to continue as a going concern.

Semnur Pharmaceuticals, Inc. reported increased operating expenses and continued net losses in its Q2 2026 Form 10-Q, while advancing its SP-102 clinical trials.

Medical Properties Trust (MPT) reported improved Q2 2026 results with increased revenues and a narrowed net loss, alongside significant debt refinancing activities.

Blue Ridge Bankshares, Inc. reported a net loss for the quarter ended June 30, 2026, driven by increased provisions for credit losses and a decline in net interest income, alongside strategic shifts in its loan portfolio.

Varex Imaging's Q3 filing reveals revenue growth driven by the Industrial segment and a significant boost from tariff refunds, though Medical segment sales declined.